The CL3 containment suite will be used for CCL’s own diagnostic testing, as well as for client projects.
CCL has been approved to provide testing services for Covid-19 antigen testing as part of the governments initiative to increase testing in the UK. CCL will initially be offering their services primarily to Cambridgeshire care homes and care home workers.
Read MoreCCL CEO Dr Tony Cooke has been supporting the Covid-19 Volunteer Testing Network.
Read MoreCambridge Clinical Laboratories is now operating a flexible working policy for employees where possible. The very nature of our work means it is essential that some of the team remain lab based…
Read MoreWe wish to reassure our global customers that we are running business as usual and are currently unaffected by Coronavirus SARS-CoV-2 (COVID-19).
Read MoreTuesday 11 February is International Day of Women and Girls in Science. To mark it we’ve asked our longest serving member of staff, Biomedical Scientist, Zoe Dawson, to tell us about her career so far and offer advice to anyone looking to follow in her footsteps.
Read MoreThe Select MDx test that we run at Cambridge Clinical Laboratories is now available through BMI Healthcare. The test is a non-invasive urine test to improve patient selection for prostate cancer diagnostic biopsy and therefore will alleviate many from going through the invasive biopsy.
Read MoreCambridge Clinical Laboratories (CCL) Christmas hours.
Read MoreCambridge Clinical Laboratories (CCL) is investing in new equipment to ready itself for expanding its current services, and introducing new options, in 2020. The first big investment is on a Roche LC480 II.
Read MoreCambridge Clinical Laboratories (CCL) is delighted to have successfully maintained its UKAS accreditation - the ISO15189 standard for medical laboratories following an annual audit.
Read MoreFollowing its recent acquisition from Novacyt Group, the Milton based pathology services company formerly known as Lab 21, has relaunched as Cambridge Clinical Laboratories (CCL). The new owner, Cambridge Pathology BV, has already invested thousands into the company in new equipment and staff.
Read More
